Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Growth Rate of the Pleural Diseases Market?

In recent years, the market size of pleural diseases has significantly expanded. Projected growth is expected to continue from $4.86 billion in 2024 to $5.23 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 7.6%. This expansion in the historical period is a result of an increasing prevalence of pleural effusion, heightening awareness of pleural diseases, a growing emphasis on early detection, an increase in healthcare facilities, and a rise in clinical trials for pleural diseases.

What Growth Rate Is Forecasted for the Pleural Diseases Market by 2029?

The market for pleural diseases is anticipated to witness robust expansion in the upcoming years, expecting to reach $6.94 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.3%. The growth during the forecast period can be credited to an increase in pleural diseases prevalence, an escalating elderly population, a surge in occupational risks, a rising number of clinical investigations, and a mounting number of diagnostic centers. Significant trends to watch during this period include progress in diagnostic methodologies, enhancement in diagnostic tools, the uptake of minimally invasive procedures, refined drug development, and the implementation of telemedicine.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22099&type=smp

Which Key Companies Are Shaping the Future of the Pleural Diseases Market?

Major companies operating in the pleural diseases market are Pfizer Inc., Merck & Co. Inc., Bristol Myers Squibb Company, GSK plc, Astrazeneca plc, Koninklijke Philips N.V., Becton Dickinson and Company, Boehringer Ingelheim International GmbH, Sanofi SA, Penn Medicine, Henry Ford Health, Dragerwerk AG, Emory Healthcare, Boston Medical Center, Cook Medical, WakeMed, Weill Cornell Medicine, Fox Chase Cancer Center, B. Braun SE, Bicakcilar, Redax S.p.a, Rocket Medical

Which Factors Are Driving Demand in the Pleural Diseases Industry?

The growth of the pleural diseases market is anticipated to be fueled by the escalating occurrence of infectious diseases. These diseases are provoked by harmful microorganisms such as fungi, parasites, bacteria, or viruses. Global travel advancements and changes in human behavior and environment contribute to the rising incidence of these diseases. Bacterial pneumonia, viral infections, and tuberculosis are examples of infectious diseases that instigate pleural disease through infection, inflammation, or the build-up of fluid in the pleural cavity. As per statistics from the National Library of Medicine, a US-based research and medical information library, in January 2023, infectious diseases were responsible for over 52 million deaths annually, endangering half of the world’s population. Additionally, about 14 million children under five years old lose their lives each year, with preventative diseases via vaccination accounting for 70% of this figure. Therefore, the spike in infectious diseases occurrence is fueling the expansion of the pleural diseases market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=22099&type=smp

How Is the Pleural Diseases Market Segmented by Several Divisions?

The pleural diseases market covered in this report is segmented –

1) By Disease Type: Pleurisy, Pleural Effusion, Pneumothelioma, Mesothelioma, Other Disease Types

2) By Treatment Modalities: Medications, Thoracentesis And Pleurodesis, Minimally Invasive Interventions, Surgical Interventions

3) By Diagnostic Tools: Imaging Techniques, Molecular Diagnostics, Thoracoscopy, Pleuroscopy

4) By End User: Hospitals And Clinics, Diagnostic Centers, Research And Academic Institutions

Subsegments:

1) By Pleurisy: Acute Pleurisy, Chronic Pleurisy, Infectious Pleurisy, Non-infectious Pleurisy

2) By Pleural Effusion: Transudative Pleural Effusion, Exudative Pleural Effusion, Malignant Pleural Effusion, Parapneumonic Pleural Effusion, Hemothorax, Chylothorax

3) By Pneumothelioma: Primary Pneumothelioma, Secondary Pneumothelioma (Metastatic), Localized Pneumothelioma, Diffuse Pneumothelioma

4) By Mesothelioma: Pleural Mesothelioma, Peritoneal Mesothelioma, Pericardial Mesothelioma, Testicular Mesothelioma

5) Other Disease Types: Pulmonary Embolism, Fibrothorax, Pneumothorax, Lung Cancer, Tuberculosis-Related Pleural Disease, Sarcoidosis

What are the Emerging Market Trends Driving the Growth of the Pleural Diseases Industry?

Leading businesses in the field of pleural diseases are concentrating on pioneering new treatment choices. These include the development of ready-to-use injections aimed at enhancing comfort, shortening preparation time, and lowering the risk of dosage errors. These ready-to-use injections are pre-mixed, pre-diluted medications that do not need any reconstitution or mixing prior to administration, offering accuracy, convenience, and a shorter preparation process. For example, Amneal Pharmaceuticals, a pharmaceutical firm based in the United States, launched PEMRYDI RTU in April 2024. This was the first ready-to-use offering of pemetrexed for injection. This product benefits individuals suffering from pleural diseases by delivering a user-friendly, ready-to-use treatment. It does away with the necessity for reconstitution or dilution, shortens the preparation time, reduces the chance of dosage errors, and enhances the accessibility of effective treatments for conditions such as malignant pleural mesothelioma.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/pleural-diseases-global-market-report

Which Regions Are Driving Growth in the Pleural Diseases Market?

North America was the largest region in the pleural diseases market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pleural diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22099

This Report Delivers Insight On:

1. How big is the pleural diseases market, and how is it changing globally?

2. Who are the major companies in the pleural diseases market, and how are they performing?

3. What are the key opportunities and risks in the pleural diseases market right now?

4. Which products or customer segments are growing the most in the pleural diseases market?

5. What factors are helping or slowing down the growth of the pleural diseases market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.